Testosterone Therapy
Testosterone Therapy is Offered at the Anti-Aging and Wellness Treatment Centers for Creams, Injections, and Pellet Implants.
Testosterone Pellet Therapy is offered for 90-120 Days
Trending
TESTOSTERONE THERAPY | ANTI-AGING | METABOLIC HEALTH
Testosterone deficiency is associated with poor body composition, decreased bone mineral density, sexual dysfunction, and depressed mood. It may also be linked to an increased risk of cardiovascular health, although more research is needed.
Testosterone replacement therapy is generally offered in three primary delivery methods:
- Injection <Go to Testosterone Injection Page>
- Creams <Go to Testosterone Cream Page>
- Pellet Implants (Superior delivery method) <Go to Pellets Page>
Testosterone deficiency afflicts approximately 30% of American males aged 40-79 years of age. Typical symptoms of testosterone deficiency include:
- Fatigue
- Negative mood, depression
- Diminished muscle tone
- Poor body composition
- Increased fat
- Diminished bone mineral density
Low testosterone is highly correlated with heart disease, hypertension, and type II diabetes. These are three of the top leading chronic diseases leading to death in the United States.
Physical | Psychological | Sexual |
Decreased bone mineral density | Depressed mood | Diminished libido |
Decreased muscle mass and strength | Diminished energy, sense of vitality, or well-being | Erectile dysfunction |
Increased body fat (BMI) | Impaired cognition & memory | Decreased morning erections |
Gynecomastia | Timidness | Decreased performance |
Fatigue | Procrastination | Difficulty climaxing |
Important Factors Related to Low Testosterone
- Testosterone deficiency is more common than once believed and often is under-diagnosed.
- Testosterone levels are inversely related to total testosterone and metabolic syndrome.
- Testosterone deficiency has a strong association with all-cause mortality.
- Testosterone deficiency is highly correlated with type-2 diabetes.
- Testosterone deficiency is associated with ED.
Testosterone Deficiency and Replacement Myths
Myth 1: Testosterone replacement causes heart attacks or increases the risk of heart attacks. This myth was started by certain interests within the medical industry to stall or scare patients away from seeking testosterone replacement therapy. A study reported in the 2015 American Heart Association Scientific Sessions involved 1,472 men ages 52 to 63 with low testosterone levels and no history of prior heart disease. The result – Healthy men who received testosterone replacement therapy did not have a higher risk of heart attack, stroke or death.
Myth 2: You need to have a testosterone level below 300 ng/dL to get testosterone replacement therapy. No so. Testosterone levels in men have been declining in the average male over the past 30 to 40 years. This is likely due to the modern diet and environmental factors. However, 300 ng/dL is no magic number. Treatment is best determined between the patient and the doctor based on blood testing, symptoms, and medical history.
Myth 3: Testosterone replacement causes prostate cancer. This myth began many years ago. It is based on poor medical science going back over the past 100 years. A 2015 Journal of Urology research study reported that over a five-year period, those receiving testosterone replacement therapy showed no link to a higher rate of aggressive prostate cancer.
Testosterone therapy is a natural solution to the modern lifestyle.
In a perfect world, we would like to imagine that the population is not 67% overweight or obese, eating the standard American diet, and hormone levels are optimal. However, the reality is not so.
The modern male has been subjected to decades of a lifestyle filled with poor food choices, exposure to environmental toxins that disrupt the endocrine system and hormones – (perhaps other unknown factors) – and as a result suffers from a number of physiological and psychological problems impacting the quality of life (QoL).
Alzheimer’s Disease and Testosterone
About two times more women than men suffer from Alzheimer’s disease. Women appear to carry an innate risk [Sozos Ch. Papasozomenos and A. Shanavas]. Testosterone is naturally much lower in women than men, and it has been shown in the lab to have benefited at prevention and/or treatment of Alzheimer’s disease in lab animals due to its neuroprotective effects.
CONTACT US TODAY FOR A CONFIDENTIAL CONSULT ON TESTOSTERONE REPLACEMENT THERAPY!
Download the article on Testosterone Deficiency by A.M. Traish, A. Morgentaler et. al. <Testosterone Deficiency Morgantaler>
Download the article on testosterone therapy by Harvard Health in May 2016. <Harvard Testosterone Deficiency>